European Antibiotics Sector Projected to Attain $13,529.8 Million by 2027, Sustaining a Resilient CAGR of 1.9%"

The European antibiotics market, a crucial component of the pharmaceutical industry, demonstrated robust growth in recent years. In 2019, its value reached an impressive $11,561.2 million, reflecting the importance of antibiotic medications in combating bacterial infections and safeguarding public health.

With the escalating demand for effective antibiotics, the market is anticipated to further expand in the coming years. By 2027, it is projected to reach a substantial market size of $13,529.8 million, exhibiting a steady compound annual growth rate (CAGR) of 1.9% from 2020 to 2027.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/request-sample/10676

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬

1. SANOFI
2. ABBOTT LABORATORIES
3. F. HOFFMANN-LA ROCHE
4. NOVARTIS INTERNATIONAL AG (SANDOZ)
5. MERCK &
6. VIATRIS
7. ABBVIE
8. PFIZER
9. GLAXOSMITHKLINE
10. BAYER AG.

 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐀𝐧𝐭𝐢𝐛𝐢𝐨𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬

1. Drug Class:

• Beta Lactam and Beta Lactamase Inhibitors: This class includes antibiotics such as penicillin, cephalosporin, carbapenem, and monobactam. Beta lactam antibiotics inhibit the formation of bacterial cell walls, while beta lactamase inhibitors prevent bacteria from deactivating the antibiotics.
• Quinolone: Quinolone antibiotics target bacterial DNA synthesis, inhibiting the growth and reproduction of bacteria.
• Macrolide: Macrolide antibiotics interfere with bacterial protein synthesis, impeding their ability to thrive and spread.
• Others: This category encompasses additional antibiotic classes that may have unique mechanisms of action or characteristics.

2. Drug Origin:

• Natural: Natural antibiotics are derived from microorganisms or other natural sources, such as certain bacteria or fungi.
• Semisynthetic: Semisynthetic antibiotics are derived from natural antibiotics but have undergone chemical modifications to enhance their effectiveness or modify their spectrum of activity.
• Synthetic: Synthetic antibiotics are entirely manufactured through chemical processes, offering precise control over their properties and characteristics.

3. Spectrum of Activity:

• Broad-spectrum Antibiotic: Broad-spectrum antibiotics are effective against a wide range of bacteria, including both Gram-positive and Gram-negative bacteria.
• Narrow-spectrum Antibiotic: Narrow-spectrum antibiotics target specific types or strains of bacteria, limiting their effectiveness to a narrower range.

4. Route of Administration:

• Oral: Antibiotics administered orally are taken through the mouth, typically in the form of tablets, capsules, or syrups.
• Intravenous: Intravenous antibiotics are directly administered into the bloodstream, allowing for rapid and effective delivery of the medication.
• Others: This category includes alternative routes of administration, such as intramuscular injections, topical applications, or inhalation, depending on the specific antibiotic and the infection being treated.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐀𝐧𝐭𝐢𝐛𝐢𝐨𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐭: https://www.alliedmarketresearch.com/european-antibiotics-market/purchase-options

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Contact:

United States
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int'l: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285
help@alliedmarketresearch.com

This release was published on openPR.